ArticleAmerican heart journal2025

Design and rationale of the CORE-TIMI 72a and CORE2-TIMI 72b trials of olezarsen in patients with severe hypertriglyceridemia.

Nicholas A Marston et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.